Topic

Articles

Company brings aboard former Pfizer exec as life sciences COO in effort to help further improve patient outcomes.

Project to focus on improving access to EstroGel. 

Collaboration aims to cut medication costs for patients with conditions ranging from high blood pressure to diabetes.

Deal to focus on development and commercialization in key emerging countries. 

Medicine indicated for patients aged 12 and older. 

Celexor Bio expected to focus on ell depletion of pathologic cells in autoimmune and inflammatory disorders.

Agency cites a need for more research to be completed. 

Deal aims to provide diabetes treatment to patients across the continent. 

Acquisition offers 300 new employees and a bigger product portfolio. 